The U.S. Food and Drug Administration issued a statement on the 5th that in view of the risk of rare blood clots after the Johnson & Johnson new crown vaccine, it was decided to limit the vaccination of johnson and johnson vaccine, and only allow some special groups to receive this vaccine.
▲ CCTV Finance "First Time" column video
The U.S. Food and Drug Administration said in a statement that after analyzing, evaluating and investigating the thrombosis reported after the Johnson & Johnson vaccine and accompanied by thrombocytopenia in the United States, it was determined that there was a risk of such a rare thrombus after receiving the Johnson & Johnson vaccine about one to two weeks, which may be life-threatening, so it decided to limit the use of the Johnson & Johnson vaccine to only individuals 18 years of age and older who cannot obtain or are not suitable for other approved COVID-19 vaccines, as well as individuals who are reluctant to receive other COVID-19 vaccines other than Johnson & Johnson vaccines.
Approved for emergency use in the United States on February 27, 2021, the Johnson & Johnson COVID-19 vaccine is a recombinant adenovirus vector vaccine that is allowed for use in people aged 18 years and older. On April 13 last year, the U.S. Drug Administration and the U.S. Centers for Disease Control and Prevention recommended a moratorium on the U.S. vaccine in light of the rare reported cases of severe thrombosis from Johnson & Johnson vaccine. On the 23rd of the same month, the two agencies issued a joint statement saying that after a comprehensive safety assessment, it was decided to resume the vaccination.
According to relevant data, as of March 18 this year, a total of 60 cases of thrombosis and thrombocytopenia after Receiving Johnson & Johnson vaccine were reported nationwide, including 9 deaths. According to the U.S. Centers for Disease Control and Prevention, as of May 5, the United States has received about 18.72 million doses of the Johnson & Johnson COVID-19 vaccine.
This article is reproduced from the WeChat public account "China Search", source: CCTV Finance